Organon & Co.
OGN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,403,000 | $6,263,000 | $6,174,000 | $6,304,000 |
| % Growth | 2.2% | 1.4% | -2.1% | – |
| Cost of Goods Sold | $2,688,000 | $2,515,000 | $2,294,000 | $2,382,000 |
| Gross Profit | $3,715,000 | $3,748,000 | $3,880,000 | $3,922,000 |
| % Margin | 58% | 59.8% | 62.8% | 62.2% |
| R&D Expenses | $469,000 | $528,000 | $471,000 | $443,000 |
| G&A Expenses | $1,552,000 | $1,682,000 | $1,449,000 | $1,432,000 |
| SG&A Expenses | $1,760,000 | $1,893,000 | $1,704,000 | $1,668,000 |
| Sales & Mktg Exp. | $206,000 | $209,000 | $255,000 | $236,000 |
| Other Operating Expenses | $0 | $0 | $0 | -$104,000 |
| Operating Expenses | $2,229,000 | $2,421,000 | $2,175,000 | $2,007,000 |
| Operating Income | $1,486,000 | $1,327,000 | $1,705,000 | $1,915,000 |
| % Margin | 23.2% | 21.2% | 27.6% | 30.4% |
| Other Income/Exp. Net | -$679,000 | -$654,000 | -$583,000 | -$386,000 |
| Pre-Tax Income | $807,000 | $673,000 | $1,122,000 | $1,529,000 |
| Tax Expense | -$57,000 | -$350,000 | $205,000 | $178,000 |
| Net Income | $864,000 | $1,023,000 | $917,000 | $1,351,000 |
| % Margin | 13.5% | 16.3% | 14.9% | 21.4% |
| EPS | 3.36 | 4.01 | 3.61 | 5.33 |
| % Growth | -16.2% | 11.1% | -32.3% | – |
| EPS Diluted | 3.33 | 3.99 | 3.59 | 5.33 |
| Weighted Avg Shares Out | 257,046 | 255,239 | 254,082 | 253,550 |
| Weighted Avg Shares Out Dil | 259,152 | 256,270 | 255,169 | 253,550 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $520,000 | $527,000 | $422,000 | $258,000 |
| Depreciation & Amortization | $277,000 | $236,000 | $212,000 | $195,000 |
| EBITDA | $1,604,000 | $1,436,000 | $1,756,000 | $1,982,000 |
| % Margin | 25.1% | 22.9% | 28.4% | 31.4% |